[ConservativeMind]

The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

[SubMareener]

I had to look up to find the drugs in each class:

Warfarin, the most frequently used oral VKA in the United States, inhibits the vitamin K-dependent carboxylation of coagulation factors II, VII, IX, and X and proteins C and S.

There are currently four NOACs available for patients with atrial fibrillation: dabigatran (Pradaxa®), rivaroxaban (Xarelto®), apixaban (Eliquis®), and edoxaban (Lixiana [Europe/Asia], Savaysa [Nth Am]. NOACs are the first-line treatment for most patients with venous thromboembolism (VTE) and for stroke prevention in atrial fibrillation (AF). NOACs have a lower propensity for drug and food interactions compared to vitamin K antagonists (VKAs) due to their individual coagulation proteins target and to the administration in fixed-dose without requiring routine coagulation monitoring.

Note that Vitamin K2 and D3 are essential for keeping calcium in the bones and out of the blood vessel walls, so a Vitamin K antagonist might not be a good thing for older patients.